EFFECTS OF LAROPIPRANT ON THE PHARMACOKINETICS (PK) OF ROSIGLITAZONE IN HEALTHY SUBJECTS

被引：0
|
作者：
Schwartz, J. I. [1 ]
Stroh, M. [2 ]
Gao, B. [1 ]
Liu, F. [1 ]
Rosko, K. [1 ]
Zajic, S. [2 ]
Sisk, C. McCrary [1 ]
Ruckle, J. [3 ]
Wagner, J. [1 ]
机构：
[1] Merck, Rahway, NJ USA
[2] Merck, West Point, PA USA
[3] Pacific Pharma Grp, Kailua, HI USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [41] PHARMACOKINETICS AND ENDOCRINE EFFECTS OF TERGURIDE IN HEALTHY-SUBJECTS
    KRAUSE, W
    TRAGER, H
    KUHNE, G
    SAUERBREY, N
    GRAF, KJ
    DOROW, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (06) : 609 - 615
  • [42] Effects of rifampin on the pharmacokinetics (PK) of lenvatinib (L) in healthy participants.
    Shumaker, Robert
    Aluri, Jagadeesh
    Fan, Jean
    Martinez, Gresel
    Thompson, Gary A.
    Ren, Min
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [43] Pharmacokinetics (PK) and pharmacodynamics (PD) of a novel nizatidine controlled release formulation in healthy subjects.
    Blum, RA
    Braverman, AJ
    Rice, P
    Johnson, FK
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1058 - 1058
  • [44] Pharmacokinetics (PK) of melagatran (M) in young and elderly healthy subjects and orthopedic surgery patients.
    Eriksson, UG
    Johansson, L
    Frison, L
    Gustafsson, D
    Mandema, J
    Karlsson, MO
    Eriksson, D
    Fager, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P24 - P24
  • [45] SAFETY AND PHARMACOKINETICS (PK) OF BELATACEPT AFTER A SINGLE ESCALATING INTRAVENOUS (IV) ADMINISTRATION IN HEALTHY SUBJECTS
    Shen, J.
    Summerill, R.
    Shen, Y.
    Pursley, J.
    Kaul, S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1114 - 1114
  • [46] Effect of licorice (Radix glycyrrhizae) on the pharmacokinetics (PK) and pharmacodynamics (PD) of midazolam in healthy subjects.
    Shon, JH
    Park, JY
    Kim, KA
    Cha, IJ
    Chun, BH
    Shin, JG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P78 - P78
  • [47] Pharmacokinetics (PK) of eletriptan (E) following escalating single oral doses in healthy male subjects
    Shah, AK
    Harris, SC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PI20 - PI20
  • [48] Tadalafil pharmacokinetics in healthy subjects
    Forgue, ST
    Patterson, BE
    Bedding, AW
    Payne, CD
    Phillips, DL
    Wrishko, RE
    Mitchell, MI
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (03) : 280 - 288
  • [49] Escitalopram pharmacokinetics in healthy subjects
    Soegaard, B
    Mengel, HB
    Rao, N
    Larsen, F
    Lundbeck, H
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S630 - S630
  • [50] Pharmacokinetics of bambuterol in healthy subjects
    Nyberg, L
    Rosenborg, J
    Weibull, E
    Jönsson, S
    Kennedy, BM
    Nilsson, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (05) : 471 - 478
12345